U.S. Health Coaching Market
United States Health Coaching Market Outlook & Forecasts 2024-2029: Growing Focus on Corporate Wellness, Advancements & New Initiatives, Growing Preference for Online and Digital Platforms
13 juin 2024 11h41 HE | Research and Markets
Dublin, June 13, 2024 (GLOBE NEWSWIRE) -- The "U.S. Health Coaching Market - Industry Outlook & Forecast 2024-2029" report has been added to ResearchAndMarkets.com's offering.The U.S. Health...
Achieve_Life_Sciences_Logo.jpg
Achieve Life Sciences Announces Initiation of ORCA-OL Clinical Trial Evaluating Long-Term Exposure of Cytisinicline in People who Smoke or Use Nicotine E-Cigarettes
29 mai 2024 08h00 HE | Achieve Life Sciences
SEATTLE and VANCOUVER, British Columbia, May 29, 2024 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), or Achieve, a late-stage pharmaceutical company committed to the global...
Achieve_Life_Sciences_Logo.jpg
Achieve Life Sciences Reports Financial Results for First Quarter 2024 and Provides Corporate Update
09 mai 2024 16h01 HE | Achieve Life Sciences
SEATTLE and VANCOUVER, British Columbia, May 09, 2024 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a late-stage pharmaceutical company dedicated to the global development and...
22157.jpg
Smoking Cessation and Nicotine Deaddiction Landscape Report 2024: Therapeutic Assessment of Novel Drug Candidates, Emerging Drugs and the Route to Commercialization
12 avr. 2024 10h04 HE | Research and Markets
Dublin, April 12, 2024 (GLOBE NEWSWIRE) -- The "Smoking Cessation and Nicotine Deaddiction - Pipeline Insight, 2024" report has been added to ResearchAndMarkets.com's offering.The global commitment...
Achieve_Life_Sciences_Logo.jpg
Achieve Life Sciences to Present at Life Science Innovation Northwest 2024 Conference
11 avr. 2024 08h00 HE | Achieve Life Sciences
SEATTLE and VANCOUVER, British Columbia, April 11, 2024 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage pharmaceutical company committed to the global development and...
Achieve_Life_Sciences_Logo.jpg
Achieve Life Sciences Announces Data from Cytisinicline ORCA Program to be Presented at the 2024 Society for Research on Nicotine and Tobacco (SRNT) Annual Meeting
20 mars 2024 08h00 HE | Achieve Life Sciences
SEATTLE and VANCOUVER, British Columbia, March 20, 2024 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage pharmaceutical company committed to the global development and...
Transparency Market Research
Smoking Cessation and Nicotine De-Addiction Market to Reach USD 27.84 billion by 2031, at a CAGR of 10.2% - Transparency Market Research, Inc.
11 mars 2024 07h30 HE | Transparency Market Research
Wilmington, Delaware, United States, March 11, 2024 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. -The global smoking cessation and nicotine de-addiction market is estimated to flourish at a...
Achieve_Life_Sciences_Logo.jpg
Achieve Life Sciences Announces Participation at Upcoming Investor Conferences
06 mars 2024 08h00 HE | Achieve Life Sciences
SEATTLE and VANCOUVER, British Columbia, March 06, 2024 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage pharmaceutical company committed to the global development and...
Achieve_Life_Sciences_Logo.jpg
Achieve Life Sciences Reaches Agreement with the FDA on Long-Term Cytisinicline Exposure Data Requirements for NDA Submission
29 févr. 2024 08h01 HE | Achieve Life Sciences
SEATTLE and VANCOUVER, British Columbia, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage pharmaceutical company committed to the global development and...
Achieve_Life_Sciences_Logo.jpg
Achieve Life Sciences Announces Pricing of up to $124.2 Million Registered Direct Offering and Concurrent Private Placement
29 févr. 2024 08h00 HE | Achieve Life Sciences
$60 million financing upfront with up to an additional $64.2 million tied to exercise of milestone-driven warrants Upfront net proceeds to provide funds to conduct clinical development of...